Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
- 17 May 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (12) , 3058-3062
- https://doi.org/10.1016/j.bmcl.2005.04.027
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Synthesis and Evaluation of Keto-Glutamine Analogues as Potent Inhibitors of Severe Acute Respiratory Syndrome 3CLproJournal of Medicinal Chemistry, 2004
- High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main ProteinaseChemistry & Biology, 2004
- Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoVFEBS Letters, 2004
- Characterization of SARS main protease and inhibitor assay using a fluorogenic substrateBiochemical and Biophysical Research Communications, 2004
- HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirusBiochemical and Biophysical Research Communications, 2004
- Sabadinine: A Potential Non-Peptide Anti-Severe Acute-Respiratory-Syndrome Agent Identified Using Structure-Aided DesignJournal of Medicinal Chemistry, 2004
- Identifying inhibitors of the SARS coronavirus proteinaseBioorganic & Medicinal Chemistry Letters, 2003
- Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 LineagePublished by Elsevier ,2003
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C ProteaseJournal of Medicinal Chemistry, 1996